Fortis Health. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
857.00
813.00
987.00
43.00
239.00
-110.00
Adjustment
444.00
307.00
99.00
407.00
418.00
426.00
Changes In working Capital
19.00
-24.00
-10.00
-12.00
-146.00
-247.00
Cash Flow after changes in Working Capital
1,321.00
1,096.00
1,076.00
438.00
511.00
69.00
Cash Flow from Operating Activities
1,100.00
822.00
865.00
485.00
171.00
-178.00
Cash Flow from Investing Activities
-889.00
-372.00
-500.00
-130.00
63.00
-3,279.00
Cash Flow from Financing Activities
-86.00
-471.00
-517.00
-142.00
-861.00
4,256.00
Net Cash Inflow / Outflow
124.00
-21.00
-152.00
212.00
-626.00
798.00
Opening Cash & Cash Equivalents
45.00
66.00
219.00
7.00
633.00
-165.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
169.00
45.00
66.00
219.00
7.00
633.00
Compare Cash Flow Results of Fortis Health.
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
857.97
935
-78.00
-8.24%
Adjustment
444.28
1644.7
-1,200.00
-72.99%
Changes In working Capital
19.66
-192.8
211.00
110.20%
Cash Flow after changes in Working Capital
1321.91
2386.9
-1,065.00
-44.62%
Cash Flow from Operating Activities
1100.1
1920.2
-820.00
-42.71%
Cash Flow from Investing Activities
-889.12
-1537.1
648.00
42.16%
Cash Flow from Financing Activities
-86.46
-311
225.00
72.20%
Net Cash Inflow / Outflow
124.52
72.1
52.00
72.70%
Opening Cash & Cash Equivalents
45.15
433.4
-388.00
-89.58%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
169.66
505.5
-336.00
-66.44%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 33.79% vs -4.99% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
1,100.10
822.25
33.79%